Search filters

List of works by Tomáš Kalinčík

Anti-inflammatory disease modifying treatment and disability progression in primary progressive multiple sclerosis: a cohort study

scientific article published on 02 November 2018

Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.

scientific article published on 9 August 2017

Arteriovenous differences of hematological and coagulation parameters in patients with sepsis

scientific article published in December 2010

Association of Inflammation and Disability Accrual in Patients With Progressive-Onset Multiple Sclerosis

scientific article published on 01 November 2018

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

scientific article published on 01 January 2019

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis.

scientific article

Clinical correlates of grey matter pathology in multiple sclerosis

scientific article

Cognitive clinico-radiological paradox in early stages of multiple sclerosis

scientific article published on 15 December 2017

Combining clinical and magnetic resonance imaging markers enhances prediction of 12-year disability in multiple sclerosis

scientific article published on 6 April 2016

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

scientific article published on 5 December 2014

Comparative effectiveness of rituximab in multiple sclerosis

scientific article published on 14 September 2020

Comparative efficacy of first-line natalizumab vs IFN-β or glatiramer acetate in relapsing MS.

scientific article published on April 2016

Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis

scientific article published on 13 January 2019

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

scientific article published on April 2015

Comparisons of therapies in different scenarios help complete the puzzle

scientific article published on 24 April 2018

Contribution of different relapse phenotypes to disability in multiple sclerosis.

scientific article published on 7 April 2016

Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.

scientific article published on 6 June 2012

Cost of multiple sclerosis in the Czech Republic: the COMS study

scientific article published on 30 September 2011

Cross cultural validation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) and the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).

scientific article published on 4 October 2012

Data quality evaluation for observational multiple sclerosis registries

scientific article

Defining reliable disability outcomes in multiple sclerosis

scientific article published on 10 September 2015

Defining secondary progressive multiple sclerosis

scientific article published on 7 July 2016

Discard volume necessary for elimination of heparin flush effect on thromboelastography

scientific article published on 01 March 2010

Disturbance of real space navigation in moderately advanced but not in early Huntington's disease.

scientific article

Early magnetic resonance imaging predictors of clinical progression after 48 months in clinically isolated syndrome patients treated with intramuscular interferon β-1a.

scientific article

Early predictors of non-response to interferon in multiple sclerosis

scientific article published on 16 March 2012

Effect of Disease Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

scientific article published on 28 December 2020

Effectiveness of multiple disease-modifying therapies in relapsing-remitting multiple sclerosis: causal inference to emulate a multiarm randomised trial

scientific article published in 2023

Effectiveness of oral multiple sclerosis therapies in clinical context

scientific article published on 15 March 2019

Environmental factors associated with disease progression after the first demyelinating event: results from the multi-center SET study

scientific article

Evolution of cortical and thalamus atrophy and disability progression in early relapsing-remitting MS during 5 years

scientific article published on 11 April 2013

Familial mesial temporal lobe epilepsy and the borderland of déjà vu.

scientific article

Has the time come to revisit our standard measures of disability progression in MS?

scientific article published on 26 October 2020

Head-to-head drug comparisons in multiple sclerosis: Urgent action needed

scientific article published on 07 October 2019

Heparinase-modified thromboelastography can result in a fibrinolytic pattern

scientific article published in August 2010

Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosis

scientific article published on 28 September 2016

Identification of multiple sclerosis patients at highest risk of cognitive impairment using an integrated brain magnetic resonance imaging assessment approach

scientific article published on 22 November 2016

Impaired ambulation and steroid therapy impact negatively on bone health in multiple sclerosis.

scientific article published on 16 June 2014

Impairment of Smooth Pursuit as a Marker of Early Multiple Sclerosis.

scientific article

Incidence of pregnancy and disease-modifying therapy exposure trends in women with multiple sclerosis: A contemporary cohort study

scientific article published on 03 January 2019

Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort

scientific article published on 7 March 2012

Interferon-β or azathioprine as add-on therapies in patients with active multiple sclerosis

scientific article published on 21 August 2012

Local response to cold in rat tail after spinal cord transection

scientific article published on 02 April 2009

Long-term disability trajectories in primary progressive MS patients: A latent class growth analysis

scientific article published on April 2017

Longitudinal MRI and neuropsychological assessment of patients with clinically isolated syndrome

scientific article published on 22 June 2014

Monitoring of radiologic disease activity by serum neurofilaments in MS

scientific article published on 09 April 2020

Multiple Sclerosis Relapses: Epidemiology, Outcomes and Management. A Systematic Review.

scientific article published on 20 May 2015

Multiple sclerosis susceptibility loci do not alter clinical and MRI outcomes in clinically isolated syndrome.

scientific article published on 11 April 2013

Observational data: Understanding the real MS world

scientific article

Olfactory ensheathing cells but not fibroblasts reduce the duration of autonomic dysreflexia in spinal cord injured rats.

scientific article published on 24 August 2016

Olfactory ensheathing cells reduce duration of autonomic dysreflexia in rats with high spinal cord injury

scientific article published on 6 November 2009

PACS Integration of Semiautomated Imaging Software Improves Day-to-Day MS Disease Activity Detection

scientific article published on 12 September 2019

Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis

scientific article

Predictors of disability worsening in clinically isolated syndrome.

scientific article published on 27 March 2015

Predictors of long-term disability accrual in relapse-onset multiple sclerosis

scientific article published on 4 May 2016

Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice.

scientific article published on 24 November 2016

Reply: Towards personalized therapy for multiple sclerosis: limitations of observational data

scientific article published on 01 May 2018

Reporting treatment outcomes in observational data: A fine balance.

scientific article

Risk of relapse phenotype recurrence in multiple sclerosis.

scientific article

Selected changes in spinal cord morphology after T4 transection and olfactory ensheathing cell transplantation

scientific article

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

scientific article published on 18 October 2013

Silent lesions on MRI imaging - Shifting goal posts for treatment decisions in multiple sclerosis

scientific article published on 20 September 2018

Stop inflammation and you stop neurodegeneration in MS - NO

scientific article published on 02 May 2017

Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.

scientific article published on 17 January 2015

The MSBase registry: Informing clinical practice

scientific article published on 23 May 2019

The effect of oral immunomodulatory therapy on treatment uptake and persistence in multiple sclerosis

scientific article published on 21 July 2015

The feasibility, reliability and concurrent validity of the MSReactor computerized cognitive screening tool in multiple sclerosis

scientific article published on 12 July 2019

Timing of high-efficacy therapy in relapsing-remitting multiple sclerosis: A systematic review

scientific article

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response.

scientific article published in September 2017

Treatment decisions in multiple sclerosis - insights from real-world observational studies.

scientific article published on 13 January 2017

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study.

scientific article published on 10 February 2017

Treatment escalation leads to fewer relapses compared with switching to another moderately effective therapy

scientific article published on 04 December 2018

Treatment response score to glatiramer acetate or interferon beta-1a

scientific article published on 06 October 2020

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

scientific article

Where there is inflammation, treatment may reduce disability progression - Yes

scientific article published on 08 October 2018

Paulina is supported by:

About Paulina

Help